# Interlink 2N3375

> Active: United States. Medical device record on deviCERTS, compiled from public registries.

- Canonical page: <https://devicerts.com/devices/interlink-2n3375>
- Manufacturer: [Baxter International Inc.](https://devicerts.com/manufacturers/baxter-international-inc) (FDA registration: United States)
- Name in the registry: INTERLINK 2N3375
- Device class: Class II (US FDA)
- FDA product code: FPA
- GMDN: Intravenous administration tubing extension set (12170)

## Registrations and authorizations

- **GUDID** · GUDID listing · United States · UDI-DI 00085412004914 · listed 2016-09-24 · status: Listed (GUDID: in commercial distribution)
- **GUDID** · FDA 510(k) · United States · K925126 · decision 1993-06-18 · decision SESE · status: Active · from GUDID

## Recalls

- Z-1269-2013 · Class II · terminated · initiated 2013-03-28: Customers have reported that when separating an individual package from its attached grouping, the adjacent package has opened, compromising its sterile barrier properties.
- Z-0471-2012 ·  · terminated · initiated 2011-12-06: During production of the IV sets, solvent was inadvertently applied to the locking collar of the male luer connector, which may have damaged the component, preventing proper engagement of the locking collar to secure a connection.
- Z-2837-2011 ·  · terminated · initiated 2011-07-06: Some of the individual extension set packages were improperly sealed, compromising the sterility of the product.
- Z-0640-06 ·  · terminated · initiated 2005-12-15: The extension sets contain microbore female luers that may crack during use, resulting in leakage of medication or incomplete delivery of medication.
- Z-0629-06 ·  · terminated · initiated 2005-12-15: The extension sets contain microbore female luers that may crack during use, resulting in leakage of medication or incomplete delivery of medication.
- Z-0634-06 ·  · terminated · initiated 2005-12-15: The extension sets contain microbore female luers that may crack during use, resulting in leakage of medication or incomplete delivery of medication.
- Z-0638-06 ·  · terminated · initiated 2005-12-15: The extension sets contain microbore female luers that may crack during use, resulting in leakage of medication or incomplete delivery of medication.
- Z-0637-06 ·  · terminated · initiated 2005-12-15: The extension sets contain microbore female luers that may crack during use, resulting in leakage of medication or incomplete delivery of medication.
- Z-0630-06 ·  · terminated · initiated 2005-12-15: The extension sets contain microbore female luers that may crack during use, resulting in leakage of medication or incomplete delivery of medication.
- Z-0641-06 ·  · terminated · initiated 2005-12-15: The extension sets contain microbore female luers that may crack during use, resulting in leakage of medication or incomplete delivery of medication.
- Z-0648-06 ·  · terminated · initiated 2005-12-15: The extension sets contain microbore female luers that may crack during use, resulting in leakage of medication or incomplete delivery of medication.
- Z-0644-06 ·  · terminated · initiated 2005-12-15: The extension sets contain microbore female luers that may crack during use, resulting in leakage of medication or incomplete delivery of medication.
- Z-0652-06 ·  · terminated · initiated 2005-12-15: The extension sets contain microbore female luers that may crack during use, resulting in leakage of medication or incomplete delivery of medication.
- Z-1424-05 ·  · terminated · initiated 2005-08-03: The extension sets contain microbore female luers that may crack during use, resulting in leakage of medication or incomplete delivery of medication.
- Z-1099-05 ·  · terminated · initiated 2005-07-06: Leaks and disconnection between the bifurcated Y-site and the set tubing may occur and result in underdelivery of medication, blood loss, and a breach of the sterile fluid pathway.
- Z-1102-05 ·  · terminated · initiated 2005-07-06: Leaks and disconnection between the bifurcated Y-site and the set tubing may occur and result in underdelivery of medication, blood loss, and a breach of the sterile fluid pathway.
- Z-1151-03 ·  · terminated · initiated 2003-07-16: There are possible pinholes or perforations in the set tubing, caused by damage that occurred during the packaging process.
- Z-1154-03 ·  · terminated · initiated 2003-07-16: There are possible pinholes or perforations in the set tubing, caused by damage that occurred during the packaging process.
- Z-1165-03 ·  · terminated · initiated 2003-07-16 · matched through shared submission K925126, may concern other models: There are possible pinholes or perforations in the set tubing, caused by damage that occurred during the packaging process.
- Z-0450-03 ·  · terminated · initiated 2002-12-18 · matched through shared submission K925126, may concern other models: Leakage may occur at the inlet port
- Z-0509-03 ·  · terminated · initiated 2002-10-17: The I.V. filter sets contain a 1.2 micron filter instead of the labeled 0.22 micron filter.
- Z-0517-03 ·  · terminated · initiated 2002-10-17: The I.V. filter sets contain a 1.2 micron filter instead of the labeled 0.22 micron filter.
- Z-0505-03 ·  · terminated · initiated 2002-10-17: The I.V. filter sets contain a 1.2 micron filter instead of the labeled 0.22 micron filter.
- Z-0522-03 ·  · terminated · initiated 2002-10-17: The I.V. filter sets contain a 1.2 micron filter instead of the labeled 0.22 micron filter.
- Z-0507-03 ·  · terminated · initiated 2002-10-17: The I.V. filter sets contain a 1.2 micron filter instead of the labeled 0.22 micron filter.
- Z-0518-03 ·  · terminated · initiated 2002-10-17: The I.V. filter sets contain a 1.2 micron filter instead of the labeled 0.22 micron filter.

## Identity

- Trade name: INTERLINK [FDA GUDID (AccessGUDID)]
- Generic name: Intravenous administration tubing extension set [FDA GUDID (AccessGUDID)]
- Model / Ref / Catalog: 2N3375 [FDA GUDID (AccessGUDID)]

## Identifiers

- Primary DI / UDI-DI: 00085412004914 [FDA GUDID (AccessGUDID)]
- 510(k) Number: K925126 [FDA GUDID (AccessGUDID)]
- FDA product code: FPA [FDA GUDID (AccessGUDID)]
- GMDN term: Intravenous administration tubing extension set (12170) [FDA GUDID (AccessGUDID)]

## Classification

- Device class: Class II [FDA GUDID (AccessGUDID)]
- Regulation number: 880.5440 [FDA GUDID (AccessGUDID)]
- GUDID distribution status: In Commercial Distribution [FDA GUDID (AccessGUDID)]

## Properties

- Supplied sterile: Yes [FDA GUDID (AccessGUDID)]
- Single use: Yes [FDA GUDID (AccessGUDID)]
- Prescription use: Yes [FDA GUDID (AccessGUDID)]
- Lot / batch number: Yes [FDA GUDID (AccessGUDID)]
- Sterilise before use: No [FDA GUDID (AccessGUDID)]
- Implantable: No [FDA GUDID (AccessGUDID)]
- Contains latex: No [FDA GUDID (AccessGUDID)]
- Over-the-counter: No [FDA GUDID (AccessGUDID)]
- Convenience kit: No [FDA GUDID (AccessGUDID)]
- Combination product: No [FDA GUDID (AccessGUDID)]
- HCT/P: No [FDA GUDID (AccessGUDID)]
- Premarket exempt: No [FDA GUDID (AccessGUDID)]
- Serial number: No [FDA GUDID (AccessGUDID)]
- Expiration date: No [FDA GUDID (AccessGUDID)]
- Manufacturing date: No [FDA GUDID (AccessGUDID)]

## Source and citation

- Cite as: Interlink 2N3375, Baxter International Inc. deviCERTS medical device catalogue. https://devicerts.com/devices/interlink-2n3375 (data as of 2026-11-22).
- Data sources: [FDA GUDID (AccessGUDID)](https://accessgudid.nlm.nih.gov/), [FDA recalls](https://open.fda.gov/apis/device/recall/)
- Registry records last synced: 2026-10-23
- Statuses computed as of: 2026-11-22
- JSON: <https://devicerts.com/devices/interlink-2n3375.json>
- Licence: [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/). The deviCERTS layout and text are licensed under CC BY 4.0. Registry data remain under their source terms: U.S. FDA data (openFDA, AccessGUDID) are U.S. public domain; EUDAMED data are subject to the European Commission reuse terms.
- Attribution: DevicErts, https://devicerts.com/devices/interlink-2n3375
- Compiled by deviCERTS (devicerts.com) from public medical device registries (EUDAMED, European Commission; U.S. FDA via openFDA; AccessGUDID, U.S. National Library of Medicine). deviCERTS is not an official register and gives no regulatory advice: the record in the registry itself prevails.
